InvestorsHub Logo
Followers 33
Posts 2930
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Friday, 04/29/2022 7:21:33 PM

Friday, April 29, 2022 7:21:33 PM

Post# of 286
ASGCT titles:

Discovery of a Novel C07:02-Resticted Epitope on MAGE-A1 and Pre-Clinical Development of an Enhanced TCR-T Cell Therapy Candidate for the Treatment of Solid Tumors.

Multiplexed TCR-T Cell Therapy: A Strategy to Enhance the Efficacy of Engineered T Cell Therapy.

Discovery of TSC-200-A02: A Natural HPV16 E7-Specific TCR-T Cell Therapy Candidate for the Treatment of HPV-Positive Solid Tumors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRX News